HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma.

Abstract
Glioblastoma (GBM) is an incurable brain tumor with inevitable recurrence. This is in part due to a highly malignant cancer stem cell (CSC) subpopulation of tumor cells that is particularly resistant to conventional treatments, including radiotherapy. Here we show that CBL0137, a small molecule anti-cancer agent, sensitizes GBM CSCs to radiotherapy. CBL0137 sequesters the FACT (facilitates chromatin transcription) complex to chromatin, resulting in cytotoxicity preferentially within tumor cells. We show that when combined with radiotherapy, CBL0137 inhibited GBM CSC growth and resulted in more DNA damage in the CSCs compared to irradiation or drug alone. Using an in vivo subcutaneous model, we showed that the frequency of GBM CSCs was reduced when tumors were pretreated with CBL0137 and then exposed to irradiation. Survival studies with orthotopic GBM models resulted in significantly extended survival for mice treated with combinatorial therapy. As GBM CSCs contribute to the inevitable recurrence in patients, targeting them is imperative. This work establishes a new treatment paradigm for GBM that sensitizes CSCs to irradiation and may ultimately reduce tumor recurrence.
AuthorsMiranda M Tallman, Abigail A Zalenski, Amanda M Deighen, Morgan S Schrock, Sherry Mortach, Treg M Grubb, Preetham S Kastury, Kristin Huntoon, Matthew K Summers, Monica Venere
JournalCancer letters (Cancer Lett) Vol. 499 Pg. 232-242 (02 28 2021) ISSN: 1872-7980 [Electronic] Ireland
PMID33253788 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020. Published by Elsevier B.V.
Chemical References
  • CBLC137
  • Carbazoles
  • Radiation-Sensitizing Agents
Topics
  • Animals
  • Brain Neoplasms (genetics, pathology, therapy)
  • Carbazoles (administration & dosage)
  • Chemoradiotherapy (methods)
  • Cranial Irradiation
  • DNA Damage (drug effects, radiation effects)
  • Female
  • Glioblastoma (genetics, pathology, therapy)
  • Humans
  • Male
  • Mice
  • Neoplasm Recurrence, Local (genetics, pathology, prevention & control)
  • Neoplastic Stem Cells (drug effects, pathology, radiation effects)
  • Primary Cell Culture
  • Radiation Tolerance (drug effects)
  • Radiation-Sensitizing Agents (administration & dosage)
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: